Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of subanesthetic dose of esketamine on anesthetic recovery
ChiCTR2000040077Phase 4Recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain and Anesthesia-related recovery impairment (ARRI) comparing Group K (esketamine) with Group N (placebo) (2 arms). Primary endpoint: anesthetic recovery time. Started Dec 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painAnesthesia-related recovery impairment (ARRI)
Beyond the preview
Go deeper on ChiCTR2000040077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040077.